Bharat Parenterals allots ₹139 crore preferential allotment
Bharat Parenterals (BPLPHARMA) said it has allotted preferential allotment of ₹139 crore. The company is valued at about ₹1,327 crore.
What happened
Bharat Parenterals (BPLPHARMA) told the exchanges on 29 September 2026 at 04:22 PM that it has allotted preferential allotment of ₹139 crore.
From the filing: "Convening of an Extraordinary general meeting on Friday, October 23, 2026 at 11:30 A.M through video conferencing or other audio-visual means, to seek necessary approval of the shareholders of the Company, for the Preferential Issue."
How big is it?
At ₹139 crore, the issue is equal to about 10.5% of the company's market value of ₹1,327 crore.
Company snapshot
Bharat Parenterals is a small-cap company, with a market value of about ₹1,327 crore.
The stock last traded at ₹1,926, against a 52-week range of ₹1,201.1–₹2,277.6 (15.4% below the high).
Before this filing the shares had moved +43.6% over the month. Average daily turnover over the last 20 sessions was about ₹2.26 crore.
Promoters held 67.20% at the end of Q1 FY27, up 0.03% points from the previous quarter. Foreign institutions owned 0.11% and domestic institutions 1.37%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 94 | 10 | 14.51 |
| Q2 FY26 | 42 | 2.7 | 3.96 |
| Q3 FY26 | 41 | 1.9 | 2.78 |
| Q4 FY26 | 57 | 1.4 | 2 |
| Q1 FY27 | 56 | 3.7 | 5.31 |
What history shows
BCEIE has no earlier fund raising filing from this company on record since May 2026.
Market-wide, 1,465 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.5%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- How the money raised is used and, for equity instruments, the dilution for existing shareholders.
In the news
Recent coverage elsewhere (links open the original publisher):
- Bharat Parenterals shares rally 25% in three sessions; Here is why stock is rising
- Bharat Parenterals Board To Consider Issuance Of Equity Shares Via Preferential Issue
- Bharat Parenterals Share Price Update After 13.30% Gain
- Bharat Parenterals schedules board meet for Sept 29 to consider preferential issue
- Bharat Parenterals Ltd Locks at Upper Circuit With 13.2% Gain — Buyers Queue, Sellers Absent
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.